Marie France Fassotte

Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Blood · 1999 · 556 citations

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation

D De Groote, P.F. Zangerle, Y. Gevaert et al. · Cytokine · 1992 · 472 citations

Inflammation, Cytokine, Immunology +10

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)

Guy Jérusalem, Yves Béguin, Fadi Najjar et al. · Annals of Oncology · 2001 · 268 citations

Positron Emission Tomography, Lymphoid Neoplasia, Oncologic Imaging +9

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Annals of Oncology · 2002 · 213 citations

Positron Emission Tomography, Medical Imaging, Diagnosis +7

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · PubMed · 2001 · 206 citations